Novo Nordisk A/S
Stocks making the biggest moves midday: Applied Materials, Novo Nordisk, Cava, Vistra and more
Check out the companies making headlines in midday trading. Applied Materials — Shares of the semiconductor manufacturer dropped 6% after Applied Materials posted disappointing fiscal second-quarter revenue. The company’s revenue of $7.10 billion was below the LSEG consensus of $7.13 billion. Semiconductor revenue of $5.26 billion also disappointed the $5.31 billion analysts were looking for. […]
Read More
Stocks making the biggest moves premarket: Charter Communications, Doximity, Novo Nordisk and more
Check out the companies making headlines before the bell. Charter Communications — The cable stock rose 7% after Charter agreed to merge with rival Cox Communications . The combined company will change its name to Cox Communications within a year. Constellation Brands — Shares popped 3.4% after Berkshire Hathaway disclosed doubled its stake in the […]
Read More
Novo Nordisk CEO to step down as competition weighs on Wegovy maker’s share price
Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024. Piroschka Van De Wouw | Reuters Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down, the Wegovy-maker said Friday, […]
Read More
Denmark’s economy boomed on drug exports — Trump’s tariffs threat won’t be what slows it down
Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that […]
Read More
Why Americans pay so much more for prescription drugs
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients. The […]
Read More
Stocks making the biggest moves midday: Alphabet, Disney, Arista Networks, Super Micro and more
Check out the companies making headlines in midday trading. Alphabet — The tech behemoth fell 8%. Eddy Cue, senior vice president of services at Apple, said on Wednesday that Apple was “actively looking at” reshaping its Safari web browser to focus on AI-powered search functions, according to a Bloomberg report . Cue made the comments […]
Read More
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won’t derail Eli Lilly’s obesity market dominance
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Despite […]
Read More
Stocks making the biggest moves premarket: Disney, Super Micro, Novo Nordisk, Uber and more
Check out the companies making headlines in premarket trading. Disney — Shares of the media and entertainment company advanced more than 7% after surpassing Wall Street’s second-quarter estimates. Disney reported adjusted earnings per share of $1.45 on revenue of $23.62 billion, while analysts polled by LSEG were looking for $1.20 per share and $23.14 billion, […]
Read More
European markets edge lower as corporate earnings remain in focus; Novo Nordisk jumps 4%
German factory orders jumped more than expected in March ERGOLDING, GERMANY – OCTOBER 25: An employee during the final check while Bavarian Minister of State Florian Herrmann attends the opening of the new electric car motor housing production line at the BMW Landshut factory on October 25, 2024 in Ergolding, Germany. Analysts are predicting a […]
Read More
Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk on Wednesday reported a better-than-expected rise in […]
Read More